Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Ballantyne

Showing results (31-40 of 113) with videos related to

Pageof 12
Sort By:
Blood|August 1, 1992
Molecular cloning and analysis of in vivo expression of murine P-selectinW E Sanders, R W Wilson, C M Ballantyne, et al.
The American Journal of Medicine|September 1, 2001
Achieving and maintaining National Cholesterol Education Program low-density lipoprotein cholesterol goals with five statinsT C Andrews, C M Ballantyne, J A Hsia, et al.
Genomics|December 11, 1992
Characterization of the murine Icam-1 geneC M Ballantyne, J E Sligh, X Y Dai, et al.
Current Opinion in Cardiology|March 1, 1997
Pathophysiology and treatment of lipid perturbation after cardiac transplantationC M Ballantyne, B el Masri, J D Morrisett, et al.
Genomics|March 1, 1991
Assignment of the gene for intercellular adhesion molecule-1 (Icam-1) to proximal mouse chromosome 9C M Ballantyne, C A Kozak, W E O'Brien, et al.
Metabolism: Clinical and Experimental|March 1, 1987
Low-density lipoprotein metabolism in cerebrotendinous xanthomatosisC M Ballantyne, G L Vega, C East, et al.
Circulation Research|March 4, 2000
A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosisC Cahilly, C M Ballantyne, D S Lim, et al.
Circulation Research|May 23, 2001
Novel polymorphisms in promoter region of atp binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapyS Lutucuta, C M Ballantyne, H Elghannam, et al.
Diabetes, Obesity & Metabolism|October 31, 2002
Impact of weight loss on the metabolic syndromeC C Case, P H Jones, K Nelson, et al.
The American Journal of Cardiology|July 27, 2001
Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: effect of 5 hydroxymethylglutaryl coenzyme A reductase inhibitors on non-high-density lipoprotein cholesterol levelsC M Ballantyne, T C Andrews, J A Hsia, et al.
Pageof 12

Showing results (31-40 of 113) with videos related to

Sort By:
Pageof 12
Blood|August 1, 1992
Molecular cloning and analysis of in vivo expression of murine P-selectinW E Sanders, R W Wilson, C M Ballantyne, et al.
The American Journal of Medicine|September 1, 2001
Achieving and maintaining National Cholesterol Education Program low-density lipoprotein cholesterol goals with five statinsT C Andrews, C M Ballantyne, J A Hsia, et al.
Genomics|December 11, 1992
Characterization of the murine Icam-1 geneC M Ballantyne, J E Sligh, X Y Dai, et al.
Current Opinion in Cardiology|March 1, 1997
Pathophysiology and treatment of lipid perturbation after cardiac transplantationC M Ballantyne, B el Masri, J D Morrisett, et al.
Genomics|March 1, 1991
Assignment of the gene for intercellular adhesion molecule-1 (Icam-1) to proximal mouse chromosome 9C M Ballantyne, C A Kozak, W E O'Brien, et al.
Metabolism: Clinical and Experimental|March 1, 1987
Low-density lipoprotein metabolism in cerebrotendinous xanthomatosisC M Ballantyne, G L Vega, C East, et al.
Circulation Research|March 4, 2000
A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosisC Cahilly, C M Ballantyne, D S Lim, et al.
Circulation Research|May 23, 2001
Novel polymorphisms in promoter region of atp binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapyS Lutucuta, C M Ballantyne, H Elghannam, et al.
Diabetes, Obesity & Metabolism|October 31, 2002
Impact of weight loss on the metabolic syndromeC C Case, P H Jones, K Nelson, et al.
The American Journal of Cardiology|July 27, 2001
Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: effect of 5 hydroxymethylglutaryl coenzyme A reductase inhibitors on non-high-density lipoprotein cholesterol levelsC M Ballantyne, T C Andrews, J A Hsia, et al.
Pageof 12